Sign In
Buy ME
$0.606
+0 (+0%)
At Close: Sep 16, 2025
23andMe CEO Anne Wojcicki considers taking company private
10:07am, Thursday, 18'th Apr 2024
23andMe CEO Anne Wojcicki is considering a proposal to take the genetic testing company private
23andMe May Disappear as Public Stock
06:35am, Thursday, 18'th Apr 2024
Battered 23andMe Holding Co. (NASDAQ: ME), its shares driven down to penny stock levels, may disappear from the public markets completely.
23andMe CEO Wojcicki considering taking firm private, filing shows
11:13pm, Wednesday, 17'th Apr 2024
23andMe co-founder and chief executive Anne Wojcicki is considering making an offer to buy the genetics testing company in a potential go-private transaction, a regulatory filing on late Wednesday sho
SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics and biopharmaceutical company, will present data on its two clinical stage prog
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
03:23am, Sunday, 24'th Mar 2024
Shares of 23andMe have been hurt severely since the company's stock market debut in 2021. Several billionaire investors acquired shares of 23andMe during the last three months of 2023.
‘There are no serious safeguards': can 23andMe be trusted with our DNA?
12:00pm, Saturday, 17'th Feb 2024
The at-home genetic testing company is dealing with financial woes and a security breach. What does that mean for customers?
23andMe considers splitting up company to revive stock price
12:25pm, Thursday, 08'th Feb 2024
23andMe reported dismal third-quarter fiscal 2024 results and discussed splitting itself in two to help juice its stock price.
23andMe shares slide more than 15% as lower services revenue hits Q3 results
10:30am, Thursday, 08'th Feb 2024
Shares of 23andMe Holding Co. fell 15.8% Thursday after the DNA-testing company fiscal third-quarter sales declined 33%, weighed down by lower consumer services and research revenue.
23andMe Holding Co. (ME) Q3 2024 Earnings Call Transcript
09:22pm, Wednesday, 07'th Feb 2024
23andMe Holding Co. (ME) Q3 2024 Earnings Call Transcript
23andMe's share price keeps on falling in the wake of hacks and losses
01:21pm, Thursday, 01'st Feb 2024
23andMe stock is down over 95% from its peak, cutting its value from $6 billion to $345 million. The genetic-testing company is facing financial and strategic challenges, and was hacked last year.
23andMe Destroyed by Hackers and Losses
07:30am, Thursday, 01'st Feb 2024
23andMe Holding Co.'s (NASDAQ: ME) plans have come under attack by investors and the media after 23andMe stock collapsed in the past year.
23andMe Breach Targeted Jewish and Chinese Customers, Lawsuit Says
04:44pm, Friday, 26'th Jan 2024
The class-action suit said the genetic testing company failed to notify customers whose personal information was compiled into “curated” lists that were sold on the dark web.
23andMe admits it didn't detect cyberattacks for months
03:21pm, Thursday, 25'th Jan 2024
In a data breach notification letter filed with regulators this weekend, 23andMe revealed that hackers started breaking into customers' accounts in April 2023 and continued through most of September.
23andMe to Report FY2024 Third Quarter Financial Results
04:05pm, Wednesday, 24'th Jan 2024
SOUTH SAN FRANCISCO, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access,
23andMe blames users for data breach, citing recycled passwords
04:40pm, Wednesday, 03'rd Jan 2024
Home DNA testing firm 23andMe is placing the blame on customers who reused login credentials for a cyber incident in which 6.9 million customers' data was exposed.
